-
Mashup Score: 0
Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker. The Fracture Risk Assessment Tool (FRAX), used to estimate risk for major osteoporotic fractures, predicted 10-year fracture risks similar to what was observed in a cohort of women from the Manitoba Bone Mineral Density Program
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Evaluate both fracture, mortality risks to inform osteoporosis treatment for older men - 3 year(s) ago
Fracture and mortality risks for men aged 80 years or older have different profiles, and an assessment of both could help to inform osteoporosis drug treatment decisions, according to a speaker. In an analysis of data from more than 3,000 older men, low bone mineral density and previous falls and fractures were associated with a higher predicted fracture risk, whereas men who were older and had
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “While many individuals in these groups will decline treatment, some will prioritize treatment. Hence, patient preferences still matter.” #osteoporosis #ASBMR2021 @llangset @ASBMR @OrthoToday https://t.co/448sn7NpRx
-
-
Mashup Score: 3
Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker. The Fracture Risk Assessment Tool (FRAX), used to estimate risk for major osteoporotic fractures, predicted 10-year fracture risks similar to what was observed in a cohort of women from the Manitoba Bone Mineral Density Program
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “FRAX risk multipliers for recent fracture ... which were developed to refine fracture prediction, require examination in other cohorts, and meanwhile should be interpreted with caution in clinical practice." #ASBMR2021 @umanitoba @ASBMR https://t.co/pZjcymMq5l
-
-
Mashup Score: 0Evaluate both fracture, mortality risks to inform osteoporosis treatment for older men - 3 year(s) ago
Fracture and mortality risks for men aged 80 years or older have different profiles, and an assessment of both could help to inform osteoporosis drug treatment decisions, according to a speaker. In an analysis of data from more than 3,000 older men, low bone mineral density and previous falls and fractures were associated with a higher predicted fracture risk, whereas men who were older and had
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “We found that mortality risk could inform treatment decisions, since the balance of fracture and mortality risk varied quite substantially." #osteoporosis #ASBMR2021 @llangset @ASBMR @OrthoToday https://t.co/448sn7NpRx
-
-
Mashup Score: 1
Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker. The Fracture Risk Assessment Tool (FRAX), used to estimate risk for major osteoporotic fractures, predicted 10-year fracture risks similar to what was observed in a cohort of women from the Manitoba Bone Mineral Density Program
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Multipliers adjusting the FRAX fracture prediction tool for recent fracture and fracture site overestimated risk for future fracture in a cohort of women from Canada, according to data presented at #ASBMR2021. @umanitoba @ASBMR @HealioRheum @OrthoToday https://t.co/U1C4WXYlg0
-
Multipliers adjusting the FRAX fracture prediction tool for recent fracture and fracture site overestimated risk for future fracture in a cohort of women from Canada, according to data presented at #ASBMR2021. @umanitoba @ASBMR @HealioRheum @OrthoToday https://t.co/pZjcymMq5l
-
-
Mashup Score: 0Evaluate both fracture, mortality risks to inform osteoporosis treatment for older men - 3 year(s) ago
Fracture and mortality risks for men aged 80 years or older have different profiles, and an assessment of both could help to inform osteoporosis drug treatment decisions, according to a speaker. In an analysis of data from more than 3,000 older men, low bone mineral density and previous falls and fractures were associated with a higher predicted fracture risk, whereas men who were older and had
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Weigh both fracture and mortality risk when considering #osteoporosis drug treatment for fracture prevention in older men, according to a speaker at #ASBMR2021. @llangset @ASBMR @OrthoToday https://t.co/13xwD1dH6O
-
Weigh both fracture and mortality risk when considering #osteoporosis drug treatment for fracture prevention in older men, according to a speaker at #ASBMR2021. @llangset @ASBMR @OrthoToday https://t.co/448sn7NpRx
-
-
Mashup Score: 2VITAL: No fracture risk reduction with supplemental vitamin D - 3 year(s) ago
Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for vitamin D deficiency or osteoporosis, according to an ancillary analysis of the VITAL trial.“In generally healthy women and men in the U.S., supplemental vitamin D3 was safe, but had no effect on fractures,” Meryl Susan LeBoff, MD, chief of the calcium and bone section in the
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
A new ancillary analysis of the VITAL trial presented at #ASBMR2021 shows #vitaminD supplementation does not reduce #fracture risk among healthy US adults. @ASBMR https://t.co/5pIVJoNLPe
-
-
Mashup Score: 0
A menarche-centered model assessing age at peak bone mineral density suggests bone loss women may begin as soon as 5 years after menarche, even among athletes, according to an analysis of longitudinal data.“Our results suggest that even individuals who maximize their bone quality through healthy behaviors in childhood and adolescence may lose bone density in their early 20s, and we do not
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
A menarche-centered model assessing age at peak bone mineral density suggests bone loss for women may begin as soon as 5 years after menarche. #ASBMR2021 @ASBMR @FRIBinghamton @binghamtonu @UpstateNews https://t.co/iI1pKt5b7b
-
-
Mashup Score: 2Bisphosphonate superior to bone-loading exercise for fracture prevention in postmenopause - 3 year(s) ago
Postmenopausal women with low bone mass saw greater gains in spine bone mineral density and less bone turnover when assigned monthly risedronate therapy compared with a 12-month regimen of impact and resistance exercises, study data show. Researchers also showed that an exercise regimen led to increased bone strength compared with either bisphosphonate therapy or a control arm assigned calcium
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “Risedronate was effective at improving bone density of the spine, and current guidelines recommend giving risedronate after a woman becomes osteoporatic." #ASBMR2021 @ASBMR @Laura_Bilek @UNMC_research https://t.co/1uXUjXYT5B
-
-
Mashup Score: 3Oral PTH Shows Promise for Osteoporosis in Early Phase 2 Study - 3 year(s) ago
If the drug demonstrates safety and efficacy in a future phase 3 clinical trial, it could become the first oral bone-building (anabolic) therapy for osteoporosis, but it”s early days.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
An investigational oral PTH met its primary efficacy outcome in a phase 2 dosing study involving postmenopausal women with low bone mineral density. https://t.co/jEkGrGFb0O #ASBMR2021 https://t.co/W7kGDiy21c
-
ICYMI: “The risk of re-fracture after a first fracture declined gradually over time but remained elevated in all age and sex subgroups for over 10 years." #ASBMR2021 @umanitoba @ASBMR @HealioRheum @OrthoToday https://t.co/pZjcymMq5l